Overview
Hepatocellular carcinoma (HCC) and metastatic liver carcinoma can present with terminal liver cell necrosis characterized by sudden elevations in liver enzymes, significant blood loss, and systemic hypotension due to compromised portal perfusion secondary to tumor-related vascular obstruction 1.Diagnosis
Sudden and marked elevation in SGOT, SGPT, and SLDH levels 1.
Evidence of large blood loss and systemic hypotension preceding death 1.
Autopsy findings of patchy necrotic areas or infarcts in noncancerous liver parenchyma, often with hemorrhagic rims 1.
Extensive tumor growth or invasion affecting intrahepatic portal branches 1.Management
Address underlying portal vein compromise through interventions targeting tumor-related vascular obstruction 1.
Manage hemodynamic instability with supportive care measures including fluid resuscitation and vasopressors 1.
Consider surgical or interventional radiology options for portal vein reconstruction or embolization based on tumor extent and patient condition 1.Special Populations
No specific details provided regarding management in pregnancy, pediatrics, elderly, or comorbidities in the given abstracts 1.Key Recommendations
Monitor for sudden elevations in liver enzymes and hemodynamic instability as potential indicators of terminal liver necrosis in HCC and metastatic liver carcinoma patients (Evidence: Weak) 1.
Aggressive hemodynamic support is crucial in managing systemic hypotension associated with terminal liver necrosis (Evidence: Weak) 1.
Evaluate and potentially intervene on tumor-related portal vein obstruction to mitigate progression to liver cell necrosis (Evidence: Expert opinion) 1.References
1 Okuda K, Musha H, Kanno H, Igarashi M, Nakano M. Localized submassive liver cell necrosis as a terminal event of liver carcinoma. Cancer 1976. link37:4<1965::aid-cncr2820370448>3.0.co;2-p)